Although MDH1 inactivation inhibits pancreatic cancer growth by suppressing glutamine metabolism41, the role of MDH1 in de novo fatty acid synthesis has not been previously studied, and may be a potential new target to manipulate fatty acid metabolism for prostate cancer treatment. Here, MDH1 is linked to familial pancreatic carcinoma.